Women's Health Market Research Reports & Industry Analysis
Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.
Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.
Women's Health Industry Research & Market Reports
-
2023-2027 Saudi Arabia Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ... Read More
-
2023-2027 Latvia Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Middle East Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - An 11-Country Database and Analysis, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 11-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ... Read More
-
2023-2027 Denmark Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Dominican Republic Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ... Read More
-
2023-2027 Albania Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 North America Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - US, Canada, Mexico - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 3-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Ukraine Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Bahrain Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Bangladesh Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Indonesia Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Poland Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Kuwait Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Switzerland Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Iran Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
Global Vulvodynia Pain Management Market - 2023-2030
... the forecast period 2023-2030. Vulvodynia is a chronic pain condition of the vulva (outer female genitals). It usually lasts over three months, and there's no known cause. Vulvodynia affects women of all age groups; the ... Read More
-
Global Breast Cancer Diagnostics Market - 2023-2030
... the forecast period 2023-2030. According to the World Health Organization, breast cancer is the most commonly diagnosed type of cancer globally. The number of registered diagnostic breast cancer cases ase count has been estimated to ... Read More
-
Israel Gynecology Drugs Market By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast and Opportunities, 2028
... Online Pharmacies), By Region, Competition, Forecast and Opportunities, 2028 Israel gynecology drugs market is expected to show an impressive growth during the forecast period, 2024-2028. The Israel gynecology drugs market is expected to boost due ... Read More
-
Maternal Mental Health Market - Global Maternal Mental Health Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Disease Indication Coverage, By Therapy Coverage, By Geographic Coverage and By Company)
... Maternal Mental Health Market Poised for Remarkable Growth, Projected to Reach US$40 Billion by 2030 The global maternal mental health market is on track to achieve a substantial valuation of US$40 billion by the close ... Read More
-
Global Ovarian Cancer Market - 2023-2030
... period 2023-2030. Ovarian cancer is a deadly gynecological cancer and is the seventh most common cancer in women globally. Most women with ovarian cancer are diagnosed at the advanced stage, which is most challenging to ... Read More
-
U.S. Emergency Contraceptive Pills Market Size, Share & Trends Analysis Report By Type (Combination Pills, Progesterone Pills, Ulipristal Acetate), By Distribution Channel (Retail Store, Online Store), By Region, And Segment Forecasts, 2023 - 2030
... Emergency Contraceptive Pills Market Growth & Trends The U.S. emergency contraceptive pills (ECPs) market size is expected to reach USD 5.1 billion by 2030, according to a new report by Grand View Research, Inc. The ... Read More
-
Global Condom Market - 2023-2030
... A condom is a thin, fitted tube worn over the penis during sex or inserted into the vagina before sex. They create a barrier that keeps semen and other body fluids from the vagina, rectum, ... Read More
-
Gynecological Cancers Therapeutics
... begin in the flat squamous cells that line the inside of the cervical, uterine, or vaginal region. Gynecological cancers can develop from infection with cancer-causing viruses types like human papillomavirus (HPV), especially HPV type 16, ... Read More
-
Surrogacy Market: By Type (Gestational Surrogacy, Traditional Surrogacy), By Technology (Intrauterine Insemination (IUI), Classical/Standard In-vitro Fertilization (IVF), In-vitro Fertilization with Intracytoplasmic Sperm Injection [ICSI]), By Age Group (Below 35 Years, 35-37 Years, 38 - 39 Years, 40-42 Years, 43-44 Years, Over 44 Years), By Service Provider (Hospitals, Fertility Clinics, Others) And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
... Years, 40-42 Years, 43-44 Years, Over 44 Years), By Service Provider (Hospitals, Fertility Clinics, Others) And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032 Surrogacy Market: By ... Read More
-
Triple Negative Breast Cancer Epidemiology Forecast - 2032
... and widely accepted classification of breast cancer is from an immunohistochemical perspective, based on the expression of the following hormone receptors: estrogen (ER), progesterone (PR), and human epidermal growth factor (HER2). Triple-negative breast cancer (TNBC) ... Read More